$410,000 of ILLUMINA INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"H.R. 1: One Big Beautiful Bill Act; provisions related to permanent Research and Development (R&D) expensing Discussions related to Artificial Intelligence Discussions related to permanent Research and Development (R&D) expensing Discussions related to Tariffs"
You can find more data on corporate lobbying on Quiver Quantitative.
ILMN Congressional Stock Trading
Members of Congress have traded $ILMN stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $ILMN stock by members of Congress over the last 6 months:
- REPRESENTATIVE THOMAS H. KEAN, JR. has traded it 2 times. They made 2 purchases worth up to $30,000 on 04/01 and 0 sales.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
ILMN Insider Trading Activity
ILMN insiders have traded $ILMN stock on the open market 8 times in the past 6 months. Of those trades, 8 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $ILMN stock by insiders over the last 6 months:
- JACOB THAYSEN (Chief Executive Officer) has made 7 purchases buying 12,350 shares for an estimated $998,674 and 0 sales.
- ANKUR DHINGRA (SVP, Chief Financial Officer) purchased 6,100 shares for an estimated $495,380
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ILMN Hedge Fund Activity
We have seen 351 institutional investors add shares of ILMN stock to their portfolio, and 483 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CORVEX MANAGEMENT LP added 2,129,449 shares (+125.2%) to their portfolio in Q1 2025, for an estimated $168,950,483
- AQR CAPITAL MANAGEMENT LLC added 1,662,093 shares (+361.7%) to their portfolio in Q1 2025, for an estimated $131,870,458
- ALLIANCEBERNSTEIN L.P. removed 1,385,581 shares (-82.0%) from their portfolio in Q1 2025, for an estimated $109,931,996
- BESSEMER GROUP INC removed 1,340,712 shares (-99.4%) from their portfolio in Q1 2025, for an estimated $106,372,090
- JACOBS LEVY EQUITY MANAGEMENT, INC added 1,152,048 shares (+11714.9%) to their portfolio in Q1 2025, for an estimated $91,403,488
- ARTISAN PARTNERS LIMITED PARTNERSHIP removed 1,053,709 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $83,601,272
- AMERIPRISE FINANCIAL INC removed 1,031,908 shares (-77.0%) from their portfolio in Q1 2025, for an estimated $81,871,580
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ILMN Analyst Ratings
Wall Street analysts have issued reports on $ILMN in the last several months. We have seen 4 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Sell" rating on 07/09/2025
- Barclays issued a "Underweight" rating on 06/24/2025
- Stephens & Co. issued a "Overweight" rating on 05/20/2025
- Piper Sandler issued a "Overweight" rating on 05/15/2025
- Guggenheim issued a "Buy" rating on 05/09/2025
- RBC Capital issued a "Outperform" rating on 04/08/2025
To track analyst ratings and price targets for ILMN, check out Quiver Quantitative's $ILMN forecast page.
ILMN Price Targets
Multiple analysts have issued price targets for $ILMN recently. We have seen 12 analysts offer price targets for $ILMN in the last 6 months, with a median target of $102.5.
Here are some recent targets:
- Sung Ji Nam from Scotiabank set a target price of $125.0 on 07/11/2025
- Patrick Donnelly from Citigroup set a target price of $80.0 on 07/09/2025
- Vijay Kumar from Evercore ISI Group set a target price of $128.0 on 07/08/2025
- Luke Sergott from Barclays set a target price of $85.0 on 06/24/2025
- Kyle Mikson from Canaccord Genuity set a target price of $99.0 on 06/11/2025
- Mason Carrico from Stephens & Co. set a target price of $105.0 on 05/20/2025
- David Westenberg from Piper Sandler set a target price of $185.0 on 05/15/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.